Moleculin Biotech Inc. held a Special Meeting of Stockholders on October 16, 2025. Stockholders approved the issuance of up to 64,864,864 shares of common stock upon the exercise of certain warrants issued on August 28, 2025. A proposal to amend the company's name from Moleculin Biotech, Inc. to Moleculin Inc. was not approved. Approval was given for a potential adjournment of the meeting, if necessary, to solicit additional proxies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-031123), on October 16, 2025, and is solely responsible for the information contained therein.